Security key
36269B105
- Security type / class
- Equity / COM
- Total 13F shares
- 8,194,999
- Total 13F value
- $15,827,926
- Share change
- +56,280
- Put/Call ratio
- 34%
- SEC-reported price per share
- $1.94
- Number of holders
- 42
- Value change
- -$302,125
- Number of buys
- 16
- Number of sells
- 25
Open additional details 1 more signal available
Report period
Q1 2026
Institutions
42
Top holders
10
GANX full security history
Ownership snapshot
Full 13F holder table
Gain Therapeutics, Inc. SEC filings
Gain Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of GANX - Gain Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MARSHALL WACE, LLP
Disclosed value leader
MARSHALL WACE, LLP
Comparable rows
0/15
Latest evidence
31 Dec 2025
13F
3/4/5
Highest disclosed value: $5,352,582
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
MARSHALL WACE, LLP has the largest disclosed position value at $5.35M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MARSHALL WACE, LLP's linked filing trail.
Disclosed position value
Top 5
MARSHALL WACE, LLP
$5.35M
Potomac Capital Management, Inc.
$3.25M
JONES FINANCIAL COMPANIES LLLP
$2.26M
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$2.2M
VANGUARD GROUP INC
$1.84M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MARSHALL WACE, LLP |
13F
Company
|
—
class O/S missing
|
$5,352,582
1,662,293 shares
|
— | 31 Dec 2025 |
| Potomac Capital Management, Inc. |
13F
Company
|
—
class O/S missing
|
$3,252,200
1,010,000 shares
|
— | 31 Dec 2025 |
| JONES FINANCIAL COMPANIES LLLP |
13F
Company
|
—
class O/S missing
|
$2,261,126
702,213 shares
|
— | 31 Dec 2025 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
—
class O/S missing
|
$2,203,604
684,349 shares
|
— | 31 Dec 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$1,835,082
569,901 shares
|
— | 31 Dec 2025 |
| Cambridge Investment Research Advisors, Inc. |
13F
Company
|
—
class O/S missing
|
$1,831,000
568,645 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
42
Shares
8,194,999
Rows available
42
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
42
Q1 2026 holders
42
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|